Search on the site
Price request

Spinal cage system Capstone

Spinal cage system Capstone

Category:Spinal surgery
Share:

Payment methods:

DESCRIPTION

The CAPSTONE® Spine Stabilization System consists of cages of various sizes made from PEEK material, which are inserted into the space between the bodies of two lumbar or lumbosacral vertebrae to support and correct the position of the vertebrae after surgical interventions aimed at creating an interbody fusion. The geometry of the implants (the presence of a cavity) allows them to be impacted with bone autografts.

No warranties, express or implied, apply to the implant. The implied warranties of merchantability or fitness for a particular purpose are excluded. Further information on warranties and disclaimers can be found in the MDT Catalog or Price List.

INDICATIONS FOR USE

The CAPSTONE® Spinal Stabilization System is indicated for use in combination with bone autografts in patients with single- or double-level degenerative disc disease (DDD) from L2 to S1. In patients with DDD, it may be associated with spondylolisthesis or grade 1 retrolisthesis. DDD - degenerative disc disease - is defined as low back pain of discogenic origin with degeneration of the disc, confirmed by anamnesis and additional research methods. Patients should have a mature skeleton, and surgery should be preceded by a six-month course of conservative treatment. CAPSTONE® can be implanted using an open technique or through a minimally invasive posterior approach, as well as an anterior or transforaminal approach. These implants should be used in conjunction with bone autografts. The CAPSTONE® installation is designed to be used in conjunction with the cage with additional stabilizing systems approved by the Federal Drug and Food Agency (FDA) for use in lumbar spine surgery.

CONTRAINDICATIONS

The implant is not intended for use on the cervical spine.

 

Contraindications include, but are not limited to, the following list:

  • Active infection or significant risk of infection.
  • Symptoms of local inflammation.
  • Fever or leukocytosis.
  • Severe obesity.
  • Pregnancy.
  • mental problems.
  • Significantly impaired anatomy due to congenital anomalies.

Other pathological conditions or diseases in connection with which the risk outweighs the potential benefit in the use of spinal surgery, such as congenital anomalies, neoplastic processes, fractures in the surgical area, an increase in ESR unexplained by other diseases, an increase in leukocytes, or a shift in the leukocyte count.

Suspected or history of metal allergy or intolerance.

A clinical case in which there is no need for spinal fusion.

A clinical case where the implants prepared for use would be too large or too small to achieve a successful outcome.

A patient who is not expected to follow postoperative recommendations.

Any other cases not described in the testimony.

Patients with known hereditary or acquired bone fragility, calcification-related diseases should not undergo such surgery.

These implants should not be used in pediatric practice or in patients with incomplete overall skeletal growth.

Spondylolisthesis, which cannot be reduced to 1 degree.

A patient with insufficient volume of soft tissues in the area of surgical intervention, insufficient amount of bone tissue or its poor quality.

A patient in whom the placement of implants would disrupt anatomical structures or interfere with physiological functions.